Literature DB >> 11473918

Trachoma.

D Mabey1, N Fraser-Hurt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11473918      PMCID： PMC1120836          DOI： 10.1136/bmj.323.7306.218

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  22 in total

1.  Doxycycline treatment of chronic trachoma.

Authors:  I Hoshiwara; H B Ostler; L Hanna; F Cignetti; V R Coleman; E Jawetz
Journal:  JAMA       Date:  1973-04-09       Impact factor: 56.272

2.  Clinical assessment of the comparative effect of terramycin and GS 2989 in the mass treatment of trachoma.

Authors:  M A Attiah; A M el Kohly
Journal:  Rev Int Trach       Date:  1973

3.  Controlled trials with trisulfapyrimidines in the treatment of chronic trachoma.

Authors:  C R Dawson; L Hanna; T R Wood; V Coleman; O C Briones; E Jawetz
Journal:  J Infect Dis       Date:  1969-06       Impact factor: 5.226

4.  Trachoma therapy: a controlled study.

Authors:  S O Foster; D K Powers; P Thygeson
Journal:  Am J Ophthalmol       Date:  1966-03       Impact factor: 5.258

5.  Minocycline effects in patients with active trachoma.

Authors:  K F Tabbara; P Summanen; P B Taylor; E M Burd; O al Omar
Journal:  Int Ophthalmol       Date:  1988       Impact factor: 2.031

6.  Failure of trachoma treatment with ophthalmic antibiotics and systemic sulfonamides used alone or in combination with trachoma vaccine.

Authors:  R L Woolridge; K H Cheng; I H Chang; C Y Yang; T C Hsu; J T Grayston
Journal:  Am J Ophthalmol       Date:  1967-05       Impact factor: 5.258

Review 7.  Global data on blindness.

Authors:  B Thylefors; A D Négrel; R Pararajasegaram; K Y Dadzie
Journal:  Bull World Health Organ       Date:  1995       Impact factor: 9.408

8.  Trachoma and blindness in the Nile Delta: current patterns and projections for the future in the rural Egyptian population.

Authors:  P Courtright; J Sheppard; J Schachter; M E Said; C R Dawson
Journal:  Br J Ophthalmol       Date:  1989-07       Impact factor: 4.638

9.  Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure.

Authors:  R Bailey; C Osmond; D C Mabey; H C Whittle; M E Ward
Journal:  Int J Epidemiol       Date:  1989-12       Impact factor: 7.196

10.  Family-based suppressive intermittent therapy of hyperendemic trachoma with topical oxytetracycline or oral doxycycline.

Authors:  S Darougar; B R Jones; N Viswalingam; R H Poirier; J Allami; A Houshmand; M A Farahmandian; J A Gibson
Journal:  Br J Ophthalmol       Date:  1980-04       Impact factor: 4.638
View more
  4 in total

1.  What more is there to learn about trachoma?

Authors:  M Melese; W Alemayehu; B Gaynor; E Yi; J P Whitcher; T M Lietman
Journal:  Br J Ophthalmol       Date:  2003-05       Impact factor: 4.638

Review 2.  Current trachoma treatment methodologies: focus on advancements in drug therapy.

Authors:  Loretta M Chiu; Guy W Amsden
Journal:  Drugs       Date:  2002       Impact factor: 9.546

3.  Efficacy and safety of short duration azithromycin eye drops versus azithromycin single oral dose for the treatment of trachoma in children: a randomised, controlled, double-masked clinical trial.

Authors:  Isabelle Cochereau; Pablo Goldschmidt; André Goepogui; Tayyab Afghani; Laurent Delval; Pascale Pouliquen; Tristan Bourcier; Pierre-Yves Robert
Journal:  Br J Ophthalmol       Date:  2006-09-27       Impact factor: 4.638

4.  Trachoma decline and widespread use of antimicrobial drugs.

Authors:  Jaya D Chidambaram; Mariko Bird; Vivian Schiedler; Alicia M Fry; Travis Porco; Ramesh C Bhatta; Hem Jha; J S P Chaudary; Bruce Gaynor; Elizabeth Yi; John P Whitcher; Susie Osaki-Holm; Thomas M Lietman
Journal:  Emerg Infect Dis       Date:  2004-11       Impact factor: 6.883
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.